enhances the activity and surface expression of T-type calcium channels through activation of Ras-ERK signaling. Am J Physiol Cell Physiol 303: C192-C203, 2012. First published May 9, 2012; doi:10.1152/ajpcell.00427.2011.-Zinc transporter-1 (ZnT-1) is a putative zinc transporter that confers cellular resistance from zinc toxicity. In addition, ZnT-1 has important regulatory functions, including inhibition of L-type calcium channels and activation of Raf-1 kinase. Here we studied the effects of ZnT-1 on the expression and function of T-type calcium channels. In Xenopus oocytes expressing voltage-gated calcium channel (CaV) 3.1 or CaV3.2, ZnT-1 enhanced the low-threshold calcium currents (IcaT) to 182 Ϯ 15 and 167.95 Ϯ 9.27% of control, respectively (P Ͻ 0.005 for both channels). As expected, ZnT-1 also enhanced ERK phosphorylation. Coexpression of ZnT-1 and nonactive Raf-1 blocked the ZnT-1-mediated ERK phosphorylation and abolished the ZnT-1-induced augmentation of IcaT. In mammalian cells (Chinese hamster ovary
LOW-VOLTAGE-ACTIVATED T-TYPE Ca 2ϩ channels (TTCC) are linked to the pathophysiology of various disease states and are recognized as universal players in a plethora of cellular functions, including differentiation and proliferation, neuronal excitability, hormone secretion, muscle contraction, cardiac pacemaker activity, and transmission of pain signals (6, 24, 32, 42) . TTCC are distinguished among voltage-gated Ca 2ϩ channels (VGCC) by their low-voltage thresholds for activation and inactivation, fast inactivation, and smaller conductance of Ba 2ϩ (49) . Molecular cloning demonstrated the existence of protein family consisting of three isoforms: voltage-gated calcium channels (CaV) 3.1, CaV3.2, and CaV3.3.
The putative structure of the TTCC ␣-subunit has the same general topology as the ␣-subunit of high-voltage-activated Ca 2ϩ channels. However, most evidence indicates that the biophysical properties of TTCC are not affected by auxiliary subunits (42, 49) . In addition, while the modulatory pathways that affect high-voltage-activated Ca 2ϩ channels have been extensively studied, the modulation of TTCC has only lately been substantiated (10) . Nevertheless, accumulating data indicate that TTCC are highly regulated at various levels. Analysis of the density of T currents (I caT ) indicates major expression changes during development, as well as in various experimental models of pathological conditions (32) . In addition, the TTCC are directly affected by endogenous ligands, such as arachidonic acid and polyunsaturated fatty acids (9, 50) , as well as by the activation of various G protein-coupled receptors (10, 20, 41) . TTCC are also modulated by several second messengers and protein kinase pathways, including CamKII, PKA, PKC, and Rho kinase (20) .
Since TTCC lacks an ␣-interaction domain, they do not interact with the regulatory ␤-subunit that normally controls trafficking to the plasma membrane of other VGCC (1) . Nevertheless, changes in the surface expression of T channels have been recently demonstrated (2, 47) . While CaV3.2 channels are markedly retained in intracellular compartments, mutations in the intracellular loop I-II of CaV3.2 have been shown to prominently enhance the surface expression of this channel and may have important pathophysiological implications in absence epilepsy (54) . CaV3 channels are not necessarily uniform in terms of regulation. For instance, when CaV3.1 and CaV3.2 are compared, various reports indicate that distinct effects are observed on the two channel types (44, 49) . In addition, the interdomain loops, which seem to have important regulatory functions, are not conserved between these two isoforms.
The transmembrane protein zinc transporter-1 (ZnT-1) is a ubiquitously expressed protein that was reported to act as an endogenous inhibitor of L-type calcium channels (LTCC) (4, 37, 46) . Recently, our group demonstrated that ZnT-1 interacts with the calcium channel ␤-subunit, leading to a reduction in the surface expression of the LTCC ␣-subunit (30) . ZnT-1 has a well-documented role in conferring resistance against zinc toxicity (14, 39, 40, 53) . In addition, ZnT-1 binds to the amino-terminal regulatory portion of Raf-1 kinase and promotes its enzymatic activity, thereby activating the Ras-ERK signaling cascade (7, 23) . Thus, as already outlined before, ZnT-1 may have important and broad regulatory roles, only parts of which are directly related to zinc homeostasis (3, 13) .
LTCC and TTCC are coexpressed in many tissues and appear to have different functions in a variety of cells, such as cardiomyocytes, pancreatic ␤-cells, and neurons (17, 38, 45) . The goal of the present study was to determine the effects of ZnT-1 on CaV3.1 and CaV3.2 compared with its recently described effect on LTCC function. Our results indicate that, in contrast to the inhibitory effect of ZnT-1 on LTCC, ZnT-1 markedly augments the activity of CaV3.1 and CaV3.2 channels. We further demonstrate that this functional augmentation relates to ZnT-1-induced activation of Ras-ERK signaling and is associated with enhanced surface expression of the channels. These findings document a novel regulatory function of ZnT-1 and a new mode of regulation of TTCC channels by the Ras-ERK signaling cascade.
EXPERIMENTAL PROCEDURES
Expression of CaV3.1, CaV3.2, and ZnT-1 in Xenopus oocytes. Oocytes of mature female Xenopus laevis frogs were excised and prepared as previously described (4, 30) . Complementary cRNAs were synthesized by in vitro transcription with T7 or an SP6 Amplicap High-Yield Message Maker Kit (Epicentre Technologies, Madison, WI). The recombinant plasmids used in these reactions were pGEM-HE-␣ 1H and pGEM-HE-␣1G (42, 43) , pSPCA1 [rabbit skeletal muscle ␣2␦ (35)], and pXen1-ZnT1 [rat SLC30A (23) , a kind gift from Dr. currents from a batch of oocytes coinjected with cRNA for CaV3.1, with or without ZnT-1. Data represent means Ϯ SE of the currents recorded from control (squares) and ZnT-1-expressing oocytes (circles). C: normalized peak currents from 4 independent experiments. Coexpression of ZnT-1 enhanced the peak CaV3.1 current by 82 Ϯ 15% (n ϭ 57 and 65 oocytes, with and without ZnT-1, P Ͻ 0.005). D: voltage dependence of the fractional conductance [conductance (G)/maximum conductance (Gmax)], derived from the data shown in A. Fitting the data with the Boltzmann equation yielded half-Gmax voltage of Ϫ33.7 Ϯ 1.1 and Ϫ39.5 Ϯ 2 mV (P Ͻ 0.05) for controls and ZnT-1-expressing oocytes, respectively. Barium current recordings in Xenopus oocytes. Current was monitored by a two-electrode voltage clamp (TEVC) using Gene Clamp 500 amplifier (Molecular Devices, Sunnyvale, CA), as previously described (4, 30) . The bath solution contained the following (in mM): 40 Ba(OH) 2, 50 NaOH, 2 KOH, and 5 HEPES (titrated to pH 7.5 with methanesulfonic acid). Currents were measured in response to 200-ms-long voltage-clamp pulses generated every 2 s from a holding potential of Ϫ80 mV to test potentials between Ϫ80 and ϩ50 mV. Barium currents in water-injected oocytes or cells injected with the cRNA of ZnT-1 alone were negligible.
E-H: similar data as in
Cell culture and transfection. Human embryonic kidney cells (HEKT-293) and Chinese hamster ovary (CHO) cells were maintained in high-glucose Dulbecco's modified Eagle's medium supplemented with (vol/vol) 1% penicillin-streptomycin, 1% L-glutamine, and 10% fetal bovine serum at 37°C in a humidified 5% CO2 incubator. HEKT-293 cells were subcultured into 60-mm dishes 1 day before transfection and seeded to reach 50 -70% confluence. Transient transfection of HEKT-293 cells was carried out utilizing calcium phosphate transfection protocol. CHO cells were transfected utilizing . Cells transfected with pEGFP-N1 were cotransfected with either SLC30A-pJJ19 or an empty pcDNA3 vector. The total amounts of plasmids and transfection reagent were similar in each treatment group. Measurements were performed 36 -48 h after transfection. In some experiments, ERK signaling was inhibited, by incubating the cells with the MEK-1 inhibitor PD-98059 (25 M). The compound was dissolved in DMSO diluted 1:500 and added to the culture 2 h before the experiment. DMSO alone was diluted 1:500 and added to all other wells of these experiments, at the same time that PD-98059 was applied.
Electrical recordings of T currents in CHO cells. Patch-clamp recordings were performed using whole cell configuration. Signals were amplified using an Axopatch 200B patch-clamp amplifier (Molecular Devices, Sunnyvale, CA) sampled at 2 kHz and filtered at 800 Hz via a four-pole Bessel low-pass filter. Data were acquired using pClamp 9.2 software (Molecular Devices) and an IBM-compatible Pentium IV computer in conjunction with a DigiData 1322A interface (Molecular Devices). The patch pipettes were pulled from borosilicate glass (Warner Instrument) with a resistance of 3-6 M⍀. For Ba 2ϩ current recordings in CHO cells, the intracellular pipette solution contained the following (in mM): 130 KCl, 5 MgATP, 5 EGTA, 10 HEPES, adjusted with KOH to pH 7.4 (300 mosmol). The extracellular solution contained the following (in mM): 140 NaCl, 4 KCl, 2 BaCl 2, 1.2 MgCl2, 11 glucose, and 5.5 HEPES, adjusted with NaOH to pH 7.4 (315 mosmol). Series resistances (5-13 M⍀) were compensated (75-90%) and periodically monitored. Barium currents in nontransfected CHO cells were negligible (not shown).
HL-1 cells. Cultured murine cardiac cells (HL-1 cells) were kindly provided by Dr. W. Claycomb (New Orleans, LA) and were maintained as described previously (3) . Briefly, cells were plated in gelatin/fibronectin-coated culture vessels and maintained in Claycomb medium (JRH Biosciences) supplemented with 10% fetal bovine serum, 0.1 mM norepinephrine, 2 mM glutamine, 100 units/ml penicillin-streptomycin. For induction of endogenous expression of ZnT-1 (3), HL-1 cells were incubated with 100 M Zn 2ϩ for 6 h and then washed and kept in regular nominally zinc-free medium until the experiment 36 h thereafter. To evaluate the effect of endothelin-1 (ET-1) on surface expression of TTCC, 30 nM ET-1 were applied for 2 h to HL-1 cells. Thereafter, surface biotinylation was performed as described below. To verify the effect of ET-1 on ERK phosphorylation, cells were exposed to ET-1 (30 nM) for 10 min, Thereafter, cells were homogenized, and Western blot analysis was performed.
Western blot analysis. To harvest cellular proteins, cultured cells were washed three times in phosphate-buffered saline (PBS), scraped with a rubber-policeman, and homogenized by sonication in 150 l Choi homogenizing buffer containing the following (in mM): 20 Tris·HCl, 320 sucrose, 0.2 EDTA, 0.5 EGTA, and a protease inhibitor mixture (Boehringer Complete Protease Inhibitor Mixture, Roche Molecular Biochemicals). The homogenate was cleared at 14,000 g for 15 min at 4°C, and the supernatant frozen and stored at Ϫ80°C for future use. Xenopus oocytes were lysed with Nonidet P-40 lysis buffer (0.5% Nonidet P-40; Igepal), containing the following (in mM): 137 NaCl, 50 NaF, 5 EDTA, 10 Tris (pH 7.5), 1 NaVO 3, and a protease inhibitor mixture as above. Lysates were cleared by low-speed centrifugation (820 g for 15 min at 4°C), and the supernatant frozen and stored at Ϫ80°C for future use. Protein concentrations were determined utilizing Bradford assay (Bio-Rad). Immunoblot analysis was performed as previously described (4, 30) . Phospho-ERK-1/2 was detected by anti-phospho-ERK-1/2 (Sigma-Aldrich). Total-ERK was detected by anti-total-ERK-1/2 (Sigma-Aldrich). ZnT-1 myc expression was detected using anti-sera against ZnT-1, as previously described (4, 30) .
Surface biotinylation. The surface expression of CaV3 channels was assessed as previously described for CaV1.2 channels (30). Briefly, HEKT-293 cells were subcultured in 60-mm culture dishes achieving 50% confluence. The following day, HEKT-293 cells were cotransfected with a plasmid containing GFP-tagged CaV3.1 (pEGFP-N1) and either ZnT-1 (SLC30A-pJJ19) or an empty vector (pcDNA3). The experiments were carried out 48 h following the transfection. All procedures were done on ice at 0°C. Cell monolayers were washed three times with ice-cold PBS, incubated for 30 min at 4°C, and shaken gently, in the presence of 0.5 mg/ml of the membraneimpermeable reagent Sulfo-NHS-SS-biotin in PBS. The cells were then washed three times with PBS supplemented with 10% BSA (Sigma) and incubated in the same solution, but without the biotin, for an additional 5 min to remove any unbound NHS-SS-biotin. Following three additional cycles of PBS washing, the cells were scraped into 150-l harvest buffer [20 mM Tris pH 8.0, 137 mM NaCl, 5 mM EDTA, 5 mM EGTA, 10% glycerol, 0.5% Triton X-100, 50 mM NaF, 20 mM benzamide (Sigma), and protease inhibitor cocktail (Roche)]. The scraped cells were then collected into Eppendorf tubes prechilled on ice, sonicated for 10 s, and centrifuged at 5,000 g for 10 min at 4°C. The supernatant was collected, and protein content was determined using the Bio-Rad assay kit with bovine serum albumin as a standard. All samples were adjusted to similar protein concentration. From each sample, 15 l were retained and marked as "total protein". Thirty microliters of Immobilized NeutrAvidin resin (Thermo Scientific) were added to the remaining samples, and the reaction mixture was gently rotated end over end at 4°C for 10 h. Thereafter, resin was spun down (6,000 g, 5 min) and washed three times with ice-cold harvest buffer. The released proteins were retained, marked as "membrane fraction", and stored at Ϫ80°C for further analysis. Western blot analysis of the total protein and membrane fraction samples was done using anti-GFP antibody (Santa Cruz Biotechnology) for detecting GFP-tagged CaV3.1. Endogenous CaV3.1 channels in HL-1 cells were detected using anti-CaV3.1 and antibodies (Alomone Laboratories). Ponceau staining was used to confirm equal protein loading.
Total internal reflection fluorescence microscopy. Analysis of total internal reflection fluorescence microscopy (TIRFM) was done as previously described (30) . CHO cells grown in a glass-bottom dish were cotransfected with CaV3.1/GFP, with or without ZnT-1. Twentyfour hours following transfection, the cells were fixed for 20 min with 4% paraformaldehyde/PBS and then imaged in standard PBS solution at room temperature. Imaging was performed on an in-house built prism-based TIRFM system, using the 488-nm line of an argon ion laser (Melles Griot) and imaged utilizing a SPOT charge-coupled device camera (Diagnostic Instruments, Sterling Heights, MI), mounted on a Zeiss Axioplan2 upright microscope with a ϫ40 1.3 numerical aperture objective (Zeiss, Jena, Germany). To quantify changes in TIRFM of EGFP-labeled proteins, fluorescent intensities were normalized according to the following equation: relative fluorescence intensity ϭ F(t)/F(e), where F(t) is the intensity of TIRFM measurements, and F(e) is the intensity of epifluorescence measurements. The relative fluorescence intensity was determined using the Image J software package.
Statistical analysis. Values were expressed as means Ϯ SE. Student's t-test or one-way ANOVA were used as required to determine statistical significance of differences between means. For results that were distributed in a non-Gaussian manner, the Mann-Whitney nonparametric test was used, as indicated. Statistical significance was set at P Ͻ 0.05. In Figs. 1-10, * signifies P Ͻ 0.05, and ** signifies P Ͻ 0.01.
RESULTS

ZnT-1 enhances TTCC function.
Regulation of TTCC by ZnT-1 was first assessed by measuring Ba 2ϩ currents in Xenopus oocytes expressing either CaV3.1 or CaV3.2 channels (Fig. 1) . Overexpression of ZnT-1 augmented the peak I caT of CaV3.1 and CaV3.2 expressing oocytes to 182 Ϯ 15 and 167.95 Ϯ 9.27% of control, respectively (Fig. 1, C and G) , and enhanced the calculated maximum conductance (G max ) of CaV3.1 and CaV3.2 expressing oocytes to 165.9 Ϯ 8.4 and 152.9 Ϯ 3.8% of control, respectively (not shown). In addition, ZnT-1 induced a small but significant shift of the half-G max voltage of CaV3.1 from Ϫ33.7 Ϯ 1.1 to Ϫ39.5 Ϯ 2 mV (Fig. 1D) and a similar shift of the half-G max voltage of CaV3.2 from Ϫ27.97 Ϯ 0.44 to Ϫ33.48 Ϯ 0.54 mV (Fig. 1H) .
ZnT-1 enhances TTCC function through activation of Ras-ERK signaling. ZnT-1 has previously been shown to bind and activate Raf-1 kinase, leading to activation of Ras-ERK signaling (7, 23) . Therefore, we investigated whether the regulatory effect of ZnT-1 on CaV3 channels is mediated by the activation of this signaling pathway. For this purpose, ZnT-1 and nonactive Raf-1 (NAF) were coexpressed in Xenopus oocytes. As expected, coexpression of NAF with ZnT-1 inhibited the ability of ZnT-1 to enhance ERK phosphorylation (Fig. 2) . In addition, NAF completely inhibited the ZnT-1-induced enhancement of I caT in oocytes expressing either CaV3.1 (Fig. 3 ) or CaV3.2 (Fig. 4) . Expression of NAF in the absence of ZnT-1 seemed to have a mild inhibitory effect on I caT by itself (not shown). Taken together, the results support the notion that ZnT-1 augments the activity of CaV3 channels through activation of Ras-ERK signaling. It should be noted that, in a different set of experiments, we also tested the effect of the MEK inhibitor PD-98059 on the ZnT-1-induced enhancement of I caT in Xenopus oocytes. Although in some experiments the drug indeed blocked the effect of ZnT-1, unexplained variability did not allow definite conclusion using this drug in Xenopus oocytes.
ZnT-1 enhances TTCC function in mammalian cells. The effect of ZnT-1 on TTCC function was further assessed in mammalian cells. Similar to the findings in oocytes, I caT increased to 166.37 Ϯ 6.37% in CHO cells coexpressing CaV3.1 and ZnT-1, compared with cells expressing CaV3.1 alone (Fig. 5,  A-C) . ZnT-1 also enhanced the calculated G max to 138.55 Ϯ 1.4% of control (Fig. 5D ) and induced a small, but significant, shift in the half-G max voltage from Ϫ37.90 Ϯ 0.46 mV in control cells to Ϫ42.30 Ϯ 0.45 mV in cells coexpressing CaV3.1 channels and ZnT-1 (Fig. 5E) .
ZnT-1 increases the surface expression of CaV3.1 channels. Recently our laboratory showed that ZnT-1 modulates the activity of LTCC by reducing membrane surface expression of its ␣-subunit (30) . In the present study, using biotinylation experiments, we evaluated the effect of ZnT-1 on the surface expression of TTCC. Coexpression of ZnT-1 and CaV3.1 in HEKT-293 cells led to an increase in the surface expression of the CaV3.1. A concomitant tendency of reduction was noted in the total expression of the channel. However, this tendency did not reach statistical significance (Fig. 6) . Interestingly, inhibition of Ras-ERK signaling by the MEK-1 inhibitor PD-98059 abolished the ZnT-1-induced translocation of CaV3.1 channels to the plasma membrane (Fig. 7) . TIRFM utilizing GFP-labeled CaV3.1 (CaV3.1:GFP) was applied to substantiate the surface expression findings and to directly quantify fluorescent-tagged CaV3.1 in the plasma membrane vicinity (28) . A relative measure of the fluorescence at the near membrane was defined as the ratio between the TIRFM signal and the conventional epifluorescence signal, representing total protein expression. Coexpression of CaV3.1 and ZnT-1 increased the relative signal of the CaV3.1: GFP at the cell surface to 158.86 Ϯ 12.5% of cells expressing CaV3.1:GFP alone. Importantly, consistent with the biotinylation results, application of the MEK-1 inhibitor PD-98059 abolished the ZnT-1-induced augmentation in the TIRFM signal of the CaV3.1:GFP (Fig. 8) . 
Ras-ERK signaling promotes surface expression of CaV3.1 channels in HL-1 cells.
Utilizing HL-1 cells, a cardiomyocyte cell line (12) , which abundantly expresses TTCC (56), we validated the effect of endogenous ZnT-1 on the endogenous surface expression of CaV3.1. The expression of ZnT-1 in a variety of cells is regulated by extracellular zinc that activates the transcription factor MTF-1 (15, 37) . Taking advantage of this phenomenon, our laboratory recently demonstrated that transient exposure of HL-1 cells to 100 M ZnSO 4 for 6 h markedly enhances ZnT-1 expression and phospho-ERK levels 36 h later (3) . In the present study, we monitored changes in the surface expression of endogenous CaV3.1 channels under similar conditions. As expected, increased ZnT-1 expression following transient exposure to zinc (Fig. 9A) was associated with enhanced surface expression of endogenous CaV3.1 channels in the HL-1 cells (Fig. 9, B-D) .
To determine whether activation of Ras-ERK signaling by means other than ZnT-1 expression can augment the surface expression of CaV3.1 channels, HL-1 cells were exposed to ET-1, a potent activator of ERK signaling (8) . Indeed, exposure of HL-1 cells to 30 nM ET-1 led to enhanced ERK-1/2 phosphorylation (Fig. 10A) and to a concomitant increase in the surface expression of endogenous CaV3.1 channels (Fig.  10, B-D) . The effect of ET-1 on CaV3.1 surface expression was abolished in the presence of the MEK inhibitor PD-98059, supporting the involvement of Ras-ERK in the trafficking of CaV3.1 channels.
DISCUSSION
TTCC are widely expressed in different cells and organs and possess several structural and electrophysiological properties that make them unique among other VGCC (42, 49) . In addition, accumulating data indicate that abnormal function of these channels has a role in the pathophysiology of various disease states, such as absence epilepsy (52), peripheral neuropathy (22, 27, 34) , cardiac hypertrophy (11), and heart failure-related arrhythmias (25) . The results of the present study indicate that ZnT-1 augments the activity of CaV3 channels and increases their plasma membrane expression. In addition, the results indicate that the modulatory effect of ZnT-1 on the activity of TTCC depends on the known function of ZnT-1 as an activator of Ras-ERK signaling (23) .
Electrophysiologically, the most prominent effect of ZnT-1, was a marked augmentation of TTCC currents. This finding was seen in both oocytes expressing CaV3.1 and CaV3.2 and was also confirmed in CHO cells expressing CaV3.1. A small but significant shift to the left in the half-G max voltage was also consistently observed. However, since we did not record the actual voltage traces of the TEVC amplifier, we cannot exclude the possibility that the left shift of the half-G max voltage was related to inadequate voltage control due to partial saturation of the TEVC amplifier. Nevertheless, the fact that we have seen this phenomenon in practically all oocyte batches (even with observed currents that were rather small as in Fig. 4 ) as well as in the patch clamped CHO cells (Fig. 5) , suggests that this shift to the left is at least partially a true phenomenon.
The effect of ZnT-1 on the Ras-ERK signaling pathway was unveiled by a genetic screen in Caenorhabditis elegans, which identified the ZnT-1 invertebrate homolog CDF-1 as an activator of Ras-mediated signaling (7) . In subsequent work, it was demonstrated that the COOH-terminus of either CDF-1 or ZnT-1 binds and promotes the biological activity of Raf-1 kinase in Xenopus oocytes (23) . Recently, in two hybrid analyses, an interaction between ZnT-1 and Raf-1 was also noted (29) . Thus the ability of ZnT-1 to augment ERK phosphorylation in the present study was expected. Interestingly, a prominent stimulatory effect of ZnT-3 on Ras-ERK signaling was also reported recently in hippocampal mossy fiber terminals (48) . However, the involved molecular mechanism(s) was not evaluated in detail in this report. It will be interesting to further investigate whether the stimulatory effect of ZnT-3 on MAPK signaling shares common features with the effect of ZnT-1 on this pathway. Also, it will be intriguing to determine the relationship between the effect of ZnT-1 on Ras-ERK signaling and its other known modulatory functions in the context of zinc toxicity and the modulation of LTCC function (see below).
There are no known phosphorylation sites for MAPK, including ERK-1/2, on the CaV3 channels (20) . However, a role of Ras-ERK signaling in the regulation of TTCC expression and function has been previously reported. Specifically, studies in cardiac myocytes have shown that the angiotensin II-induced enhancement of T currents is mediated by angiotensin 1 (AT1) receptors and involves the activation of MEK-1/2 pathway (18) . In their study, Ferron et al. (18) reported an increase in the mRNA level of CaV3.1 and an increase in the current density of both CaV3.1 and CaV3.2 following AT1 activation. Recently, these findings were substantiated when Morishima et al. showed an increase in the mRNA levels and current density for both CaV3.1 and CaV3.2 following 24-h stimulation of AT1 receptors in rat neonatal cardiomyocytes, in conjunction with increased phosphorylation of ERK-1/2 (36) . In the present study, looking specifically on the surface expression of CaV3.1 in heterologously expressed systems, a substantial increase was noted in the presence of ZnT-1 and confirmed by two independent experimental methods: biotinylation experiments and TIRFM analysis. Using biotinylation experiments of HL-1 cells, we could further demonstrate that transient exposure to zinc, leading to the induction of ZnT-1 expression and Ras-ERK activation (3), augments the trafficking of endogenous CaV3.1 channels to the plasma membrane. Of note, this manipulation did not affect the total expression of CaV3.1 (Fig.  9) . To further evaluate the involvement of Ras-ERK signaling in trafficking of CaV3.1 channels, we exposed HL-1 cells to ET-1, a potent activator of ERK signaling (8) known to potentiate I CaT in cardiomyocytes (19, 21) . Indeed, ET-1 induced marked activation of ERK signaling and concomitantly augmented the trafficking of endogenous CaV3.1 channels to the plasma membrane (Fig. 10) . Moreover, the effect of ET-1 on TTCC trafficking was abolished in the presence of PD-98059, supporting the notion that this effect of ET-1 is indeed dependent on Ras-ERK activation. Unfortunately, single HL-1 cells demonstrate huge variability in their TTCC currents (55, 56) . Therefore, experiments to assess the effects of various manipulations on TTCC currents are not straightforward in these cells.
Further experiments are needed to elucidate the molecular mechanisms underlying Ras-ERK activation-induced trafficking of CaV3 channels. In addition, it will be important to evaluate whether various proteins in the Ras-ERK cascade may associate with the CaV3 channels following activation of this signaling pathway, and whether ZnT-1 may be involved in such interaction. Of note, in the present study, enhanced surface expression was only shown for CaV3.1. Therefore, we cannot exclude the possibility that ZnT-1 affect CaV3.1 and CaV3.2 through different mechanisms, depending on the channel type. Interestingly, a recent study by Dey et al. (16) found that the stimulatory effect of leukemia inhibitory factor on TTCC function in HEKT-293 cells was associated with increased membrane expression of GFP-tagged CaV3.2 channels and was blocked by the MEK-1/2 inhibitor U-0126.
LTCC and TTCC are coexpressed in a variety of cells and organs and appear to have differential roles in functional terms (17, 38, 45) . Our laboratory's recent reports indicate that ZnT-1 inhibits the LTCC by interaction with its ␤-subunit, which leads to a reduction in the surface expression of the LTCC ␣-subunit (30) . Therefore, based on our present and previous findings, it appears that ZnT-1 has an important functional role in regulation of the delicate balance between the surface expression and function of LTCC and TTCC. While the actual domain of interaction between ZnT-1 and the ␤-subunit has not yet been identified, it will be intriguing to evaluate whether there is a relationship between the ability of ZnT-1 to bind Raf-1 and thereby augment I CaT , and its ability to interact with the LTCC ␤-subunit, leading to LTCC inhibition.
ZnT-1 is a member of a 10-gene protein family and has a putative role in zinc homeostasis. Among the ZnT proteins, ZnT-1 is the most ubiquitously expressed and is the only family member that has a well-documented ability to reduce the extracellular levels of Zn 2ϩ and thereby confer resistance against zinc toxicity (13, 37, 39, 40) . The expression of ZnT-1 is regulated through the metal-responsive transcription factor MTF-1 (26) and is enhanced by exposure of cells to increased levels of Zn 2ϩ (13, 31, 33, 37) . Considering the well-known sensitivity of CaV3 channels to extracellular levels of Zn 2ϩ (20, 51) , our present data may suggest a regulatory feedback loop in which Zn 2ϩ , which is released from presynaptic vesicles of glutamatergic neurons in the brain (5), inhibits the local activity of CaV3 channels. On the other hand, the released Zn 2ϩ also increases the local expression of ZnT-1, which restores the activity of CaV3 channels by activation of Ras-ERK signaling.
In summary, the present study elucidates a modulatory effect of ZnT-1 on the activity of CaV3.1 and CaV3.2 channels. The stimulatory effect of ZnT-1 on TTCC function is in contrast to the previously described role of ZnT-1 as an inhibitor of LTCC function. We have shown that the effect of ZnT-1 on TTCC results from its known biological activity as an activator of Ras-ERK signaling and involves enhanced trafficking of CaV3.1 channels to the plasma membrane. The above findings are likely to bear important functional implications due to the involvement of TTCC in a variety of biological processes.
